Group 1 - The core viewpoint is that AI-enabled new material research and development is a significant trend for technological upgrades in the industry [2] - The company will continue to leverage intelligent driving to empower product development and industrial upgrades [2] - This strategy aims to establish a solid foundation for the company's long-term growth potential [2]

（编辑 楚丽君） 证券日报网讯 1月26日，万盛股份在互动平台回答投资者提问时表示，公司股价表现受多重外部因素叠 加影响：全球层面，国际地缘冲突、欧美通胀压力仍在持续，全球经济复苏乏力导致化工产品终端需求 不及预期；国内层面，行业产能结构性扩张带来供给侧竞争加剧，主要产品出现阶段性供大于求，直接 导致产品毛利及毛利率承压下滑。面对行业普遍的经营压力，公司管理层始终积极应对：一方面持续强 化研发创新与市场开拓，稳步推进高附加值产品布局；另一方面深入开展降本增效，已实现营业收入同 比增长，经营性现金流保持稳定流入，但受大额固定资产折旧摊销、资产减值等因素影响，公司经营业 绩仍面临较大压力。关于回购，公司的回购计划自公司股东会审议通过回购股份方案之日起12个月内 （即2025年4月29日～2026年4月28日）通过二级市场回购，回购的股份用于注销。公司严格按照既定方 案，结合二级市场股价波动、交易窗口期等实际情况有序实施，不存在任何"打压股价后买入"的行为， 公司将根据二级市场情况及既定的方案有序推进回购股份的事宜，并在每个月的月初披露股份回购的进 展公告。 ...

Core Viewpoint - The company expects a negative net profit for the fiscal year 2025, with a projected net profit attributable to shareholders ranging from -29 million to -20 million yuan, and a net profit after deducting non-recurring gains and losses estimated between -31 million and -22 million yuan [1] Group 1: Financial Performance - The company reported a loss in performance during the reporting period, primarily due to short-term operational pressures and the need to balance long-term strategic planning [1] - The decline in sales volume for products such as dye intermediates, paper chemicals, and pharmaceutical and agricultural intermediates is attributed to weak industry demand and intensified market competition [1] - The prices of major products have decreased to varying degrees compared to the previous year, leading to a decline in profit margins [1] Group 2: Investment and R&D - Increased investment in new product development and upgrades to existing products has resulted in higher R&D expenses, negatively impacting current profits [1]

Core Viewpoint - Yuxin Co., Ltd. is expected to report a net profit attributable to shareholders of the listed company for 2025 in the range of -50 million to -35 million yuan, indicating a significant year-on-year decrease of 117.37% to 124.32% in net profit excluding non-recurring gains and losses [1] Group 1: Performance Forecast - The company anticipates a net profit attributable to shareholders for 2025 to be between -50 million and -35 million yuan [1] - The expected net profit excluding non-recurring gains and losses is projected to be between -70 million and -50 million yuan, reflecting a year-on-year decline of 117.37% to 124.32% [1] Group 2: Reasons for Performance Change - The company's main products, including methyl tert-butyl ether, maleic anhydride, isopropanol, and butanone, are facing price pressure due to changes in industry supply and demand dynamics, leading to a narrowing price spread between products and raw materials [1] - The shutdown of the isooctane facility has also negatively impacted gross margins [1] - The subsidiary Boke New Materials' light hydrocarbon comprehensive utilization project faced challenges during trial production due to adverse weather and infrastructure issues, resulting in high material loss and switching costs [1] - Scheduled maintenance at subsidiaries Yuxin Chemical and Yuxin New Materials, along with a temporary shutdown due to a safety incident at Yuxin Chemical, affected production volumes [1] - The biodegradable materials market is currently in a downturn due to policy and demand factors, leading to the non-operation of Boke New Materials' PBAT production facility and the need for impairment provisions on related assets [1]

2025年上半年，该子公司不仅实现了6797万元的净利润，还受益于汇率波动产生了汇兑收益。马来西亚 基地的建设也在稳步推进中，尽管目前尚处于土建阶段，但公司已与客户洽谈未来可落地的产品订单。 这一基地将主要承接专利期内植保产品的CDMO业务，预计1至2年内将有产品开始投产。 联化科技是全球领先的化学和工程解决方案提供商。深耕植保行业20余年，致力于以CDMO业务合作模 式，为核心客户提供覆盖完整产品生命周期的研发、生产及供应链一站式解决方案，是全球五大原研植 保公司的战略合作伙伴，得到客户广泛的认可。 公司技术领先地位源于持续不断的研发投入，特别是在绿色生产工艺和新技术领域的前瞻性布局。2025 年上半年，公司研发投入达1.59亿元，同比增长14%。虽然专利数量同比有所减少，但公司更注重高价 值专利布局。在具体技术领域，公司取得了多项突破。 中金公司研报认为，技术突破方面，公司披露在液液分离技术研究方面针对特定项目开发了绿色吸附技 术，避免传统精馏分离技术的高能耗、高投资，计划2025 年年末完成中试放大验证。在生物技术领 域，公司完成多个绿色酶催化技术的项目开发，并完成中试放大验证；公司还完成了生物发酵平台 ...

从资金流向上来看，当日化学制品板块主力资金净流出7.18亿元，游资资金净流入5827.03万元，散户资 金净流入6.6亿元。化学制品板块个股资金流向见下表： | 代码 | 名称 | 主力净流入 (元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 002165 | 红宝丽 | 3.47 Z | 17.02% | -1.53 Z | -7.50% | -1.94 Z | -9.52% | | 600309 万华化学 | | 1.68亿 | 3.51% | -4772.48万 | -1.00% | -1.20 Z | -2.51% | | 002326 | 永太科技 | 1.60 Z | 7.14% | -7695.38万 | -3.43% | -8335.25万 | -3.71% | | 600230 沧州大化 | | 1.09 Z | 12.89% | -3504.91万 | -4.14% | -7419.85万 | -8.75% | | 002166 ...

免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每经头条（nbdtoutiao）——国际金价冲破5000美元！7年涨了280%，什么时候才见顶？专家：关键还 看美元，重点关注国际货币体系、降息和科技革命 （记者 王晓波） 每经AI快讯，富淼科技1月26日晚间发布业绩预告，预计2025年年度实现归属于母公司所有者的净利润 与上年同期相比，将实现扭亏为盈，实现归属于母公司所有者的净利润1280万元~1900万元。业绩变动 主要原因是，报告期内，因公司在内销市场上聚焦高附加值市场，主动剥离低毛利化学品业务，给内销 业务的销售造成短期压力，内销化学品收入同比下降。但公司积极开拓海外市场，外销化学品收入同比 增长。同时因园区内企业需求的下降，导致蒸汽与氢气销量减少。报告期内，得益于公司业务组合的优 化与高附加值产品占比提升，导致整体毛利率同比增长。公司于2022年12月发行可转换公司债券，报告 期内公司募投项目转固导致计提相应的部分利息费用化，以及美元汇率的影响导致财务费用增加。 每日经济新闻 ...

报告期内，因公司在内销市场上聚焦高附加值市场，主动剥离低毛利化学品业务，给内销业务的销售造 成短期压力，内销化学品收入同比下降。但公司积极开拓海外市场，外销化学品收入同比增长。同时因 园区内企业需求的下降，导致蒸汽与氢气销量减少。报告期内，得益于公司业务组合的优化与高附加值 产品占比提升，导致整体毛利率同比增长。 格隆汇1月26日丨富淼科技(688350.SH)公布，经公司财务部门初步测算，预计2025年年度实现归属于母 公司所有者的净利润与上年同期（法定披露数据）相比，将实现扭亏为盈，实现归属于母公司所有者的 净利润1,280.00万元到1,900.00万元。归属于母公司所有者扣除非经常性损益后的净利润1,100.00万元到 1,650.00万元。 ...

Market Performance - On January 26, A-shares experienced a collective adjustment, with the Shanghai Composite Index falling by 0.09% to 4132.61 points, the Shenzhen Component Index dropping by 0.85% to 14316.64 points, and the ChiNext Index decreasing by 0.91% to 3319.15 points [1] Fund Manager Changes - From January 24 to January 26, a total of 39 fund managers underwent changes, with 544 fund products experiencing manager departures in the past 30 days [3] - The reasons for the changes included 18 managers leaving due to job changes, 2 due to personal reasons, and 1 due to the end of an agency role [3] - Notably, 47 fund products announced new fund manager appointments during the same period, involving 20 different managers [5] Fund Manager Performance - Fund manager Xu Yizun currently manages assets totaling 54.60 billion yuan, with the highest return product being the Huatai-PineBridge CSI 500 Index Enhanced A, which achieved a return of 132.77% over 10 years and 66 days [5] Fund Research Activity - In the past month (December 27 to January 26), Bosera Fund conducted the most company research, engaging with 46 listed companies, followed by Huaxia Fund with 43 and Southern Fund with 36 [6][7] - The chemical products industry was the most researched sector, with 196 instances, followed by the automotive parts industry with 179 instances [6][7] Individual Stock Research - The most researched stock in the past month was Dajin Heavy Industry, with 67 fund management companies participating in the research, followed by Chaojie Co. and Haitan Ruisheng, each with 57 [8][9] - In the last week (January 19 to January 26), Dajin Heavy Industry remained the top focus, with the same number of fund institutions involved [8][9]

| 香农芯创 | 3.14 | 5.14亿元 | 电子元件 | | --- | --- | --- | --- | | 润泽科技 | 6.29 | 5.00亿元 | 互联网服 | | 工商银行 | 0.42 | 4.72亿元 | 银行 | | 沃尔核材 | 6.04 | 4.47亿元 | 非金属材 | | 兴业证券 | 3.2 | 4.28亿元 | 证券 | | 鲁抗医药 | 10 | 3.99亿元 | 化学制室 | | 中际旭创 | 0.82 | 3.87亿元 | 通信设; | | 红 宝 丽 | 9.99 | 3.47亿元 | 化学制品 | | 光环新网 | 8.16 | 3.43亿元 | 互联网服 | *数据仅供参考，不构成投资建议 据交易所数据显示，截至1月26日收盘，主力资金流入前20的股票分别为： 网宿科技（17.00亿元）、 天孚通信（11.36亿元）、 新易盛（9.42亿元）、 中信 证券（8.75亿元）、 亨通光电（8.21亿元）、 大位科技（7.38亿元）、 澜起科技（7.34亿元）、 北方稀土（7.26亿元）、 优刻得W（6.74亿元）、 长飞光纤 （5.54亿元）、 洛阳钼业（5.52 ...